Condition: Intrahepatic Cholangiocarcinoma · Cholangiocarcinoma, Intrahepatic · Sponsor: Rutgers, The State University of New Jersey
The aim of the current study is to determine the potential efficacy of liver transplantation in the form of patients' overall survival (OS) after neoadjuvant systemic therapy in patients with biologically responsive locally advanced non-metastatic intrahepatic cholangiocarcinoma (iCCA) in comparison to patients historically treated with chemotherapy alone.
This description comes directly from the study's public registry record.
Melissa Lugardo · 973-972-8412 · lugardme@uhnj.org
Angenie Preval, PA · prevalan@uhnj.org
Always discuss trial participation with your own doctor first.
| Rutgers New Jersey Medical School | Newark, New Jersey, United States | Recruiting |
| University Hospital | Newark, New Jersey, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06140134